Filtrado por: Materia
xmlui.dri2xhtml.structural.pagination-info.nototal
Immunotherapy (2) |
Pembrolizumab (2) |
Adjuvant (1) |
Biomarkers (1) |
Breast cancer (1) |
MDSCs (1) |
Melanoma (1) |
Patient-reported outcomes (1) |
PD-L1 (1) |
Phase II (1) |
Immunotherapy (2) |
Pembrolizumab (2) |
Adjuvant (1) |
Biomarkers (1) |
Breast cancer (1) |
MDSCs (1) |
Melanoma (1) |
Patient-reported outcomes (1) |
PD-L1 (1) |
Phase II (1) |